[KROS] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[KROS] Keros Therapeutics, Inc.
Announcement Date
03-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 20.01%
YoY- 6.18%
Quarter Report
KROS's Result
KROS's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
Revenue 388 8 0 0 2,500 2,500 -31.07%
PBT -52,956 -39,440 -23,509 -20,335 -12,036 -3,549 71.59%
Tax 0 -210 -4,467 -38 -156 -1,217 -
NP -52,956 -39,440 -19,042 -20,297 -12,036 -3,549 71.59%
Tax Rate - - - - - - -
Total Cost 53,344 39,448 19,042 20,297 14,536 6,049 54.48%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
NP Margin -13,648.45 -493,000.00 0.00 0.00 -481.44 -141.96 148.97%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
EPS -1.47 -1.33 -0.75 -0.87 -0.60 -0.40 29.69%
EPS Diluted -1.47 -1.33 -0.75 -0.87 -0.60 -0.40 29.69%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.